Hugel, Inc. (KOSDAQ:145020)
South Korea · Delayed Price · Currency is KRW 182,800
-800 (-0.44%)
Oct 8, 2026, 3:30 PM KST
Hugel Market Cap
Hugel has a market cap or net worth of 1.97 trillion as of October 8, 2026. It is the 8,290th most valuable company in the world and the 217th biggest in South Korea. Its market cap has decreased by 35.94% in one year.
Market Cap
1.97T
Enterprise Value
1.43T
Revenue
479.57B
Global Rank
Country Rank
#217 South Korea
PE Ratio
12.69
ChartMarket Cap Chart
Since December 24, 2015, Hugel's market cap has increased from 552.70B to 1.97T, an increase of 257.31%. That is a compound annual growth rate of 12.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 1.97T | -20.68% |
| Dec 30, 2025 | 2.49T | -19.40% |
| Dec 30, 2024 | 3.09T | 84.38% |
| Dec 28, 2023 | 1.68T | 4.84% |
| Dec 29, 2022 | 1.60T | -14.29% |
| Dec 30, 2021 | 1.86T | -20.74% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| LigaChem Biosciences | 3.03T |
| Peptron | 3.02T |
| ABL Bio | 2.88T |
| SK bioscience | 2.85T |
| OliX Pharmaceuticals | 2.66T |
| Voronoi | 2.61T |
| D&D Pharmatech | 1.97T |
| Kolon TissueGene | 1.37T |